{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:57:53Z","timestamp":1777903073813,"version":"3.51.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1007\/s11906-003-0059-0","type":"journal-article","created":{"date-parts":[[2007,8,29]],"date-time":"2007-08-29T04:29:19Z","timestamp":1188361759000},"page":"505-512","source":"Crossref","is-referenced-by-count":12,"title":["Impact of female hormones on blood pressure: Review of potential mechanisms and clinical studies"],"prefix":"10.1007","volume":"5","author":[{"given":"Jane Morley","family":"Kotchen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore A.","family":"Kotchen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"59_CR1","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","volume":"340","author":"ME Mendelsohn","year":"1999","unstructured":"Mendelsohn ME, Karas RH: The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999, 340:1801\u20131811. In this review, potential mechanisms for a cardiovascular protective effect of estrogens are described.","journal-title":"N Engl J Med"},{"key":"59_CR2","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/01.CIR.98.12.1158","volume":"98","author":"M Gehard","year":"1998","unstructured":"Gehard M, Walsh BW, Tawakol A, et al.: Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation 1998, 98:1158\u20131163.","journal-title":"Circulation"},{"key":"59_CR3","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1161\/hc4001.097035","volume":"104","author":"A Wakatsuki","year":"2001","unstructured":"Wakatsuki A, Okatani Y, Ikenoue N, et al.: Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen. Circulation 2001, 104:1773\u20131778.","journal-title":"Circulation"},{"key":"59_CR4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00004872-200202000-00013","volume":"20","author":"L Zhang","year":"2002","unstructured":"Zhang L, Kosake H: Sex-specific acute effect of estrogen on endothelium-derived contracting factor in the renal artery of hypertensive Dahl rats. J Hypertens 2002, 20:237\u2013246.","journal-title":"J Hypertens"},{"key":"59_CR5","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1161\/01.CIR.0000014618.91633.67","volume":"105","author":"S Wassmann","year":"2002","unstructured":"Wassmann S, Laufs U, Stamenkovic D, et al.: Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhances nitric oxide production. Circulation 2002, 105:2083\u20132091.","journal-title":"Circulation"},{"key":"59_CR6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/01.RES.77.5.936","volume":"77","author":"RE White","year":"1995","unstructured":"White RE, Darkow DJ, Lang JL: Estrogen relaxes coronary arteries by opening BKCa channels through a cGMPdependent mechanism. Circ Res 1995, 77:936\u2013942.","journal-title":"Circ Res"},{"key":"59_CR7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0039-128X(96)00007-4","volume":"61","author":"WKH Oelkers","year":"1996","unstructured":"Oelkers WKH: Effects of estrogen and progestogens on the renin-aldosterone system and blood pressure. Steroids 1996, 61:166\u2013171. The effects of estrogens and progesterone on the renin-aldosterone system, sodium excretion, and blood pressure are described.","journal-title":"Steroids"},{"key":"59_CR8","first-page":"R1202","volume":"275","author":"X He","year":"1998","unstructured":"He X, Wang W, Crofton J, et al.: Effect of 17 beta-estradiol on sympathetic activity and pressor response to phenylephrine in ovariectomized rats. J Appl Physiol 1998, 275:R1202-R1208.","journal-title":"J Appl Physiol"},{"key":"59_CR9","first-page":"R1030","volume":"276","author":"M Mohamed","year":"1999","unstructured":"Mohamed M, El-Mas M, Abdel-Rahman A: Estrogen enhancement of baroreflex sensitivity is centrally mediated. J Appl Physiol 1999, 276:R1030-R1037.","journal-title":"J Appl Physiol"},{"key":"59_CR10","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/01.CIR.101.8.862","volume":"101","author":"CT Minson","year":"2000","unstructured":"Minson CT, Halliwill JR, Young TM, et al.: Influence of the menstrual cycle on sympathetic activity, baroreflex sensitivity, and vascular transduction in young women. Circulation 2000, 101:862\u2013868.","journal-title":"Circulation"},{"key":"59_CR11","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1161\/01.CIR.103.24.2909","volume":"103","author":"BE Hunt","year":"2001","unstructured":"Hunt BE, Taylor A, Hamner JW, et al.: Estrogen replacement therapy improves baroreflex regulation of vascular sympathetic outflow in postmenopausal women. Circulation 2001, 103:2909\u20132914.","journal-title":"Circulation"},{"key":"59_CR12","first-page":"H1539","volume":"274","author":"RE Meersman De","year":"1998","unstructured":"De Meersman RE, Zion AS, Giardina EGV, et al.: Estrogen replacement, vascular-distensibility, and blood pressure in postmenopausal women. Am J Physiol 1998, 274:H1539-H1544.","journal-title":"Am J Physiol"},{"key":"59_CR13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/01.CIR.94.2.122","volume":"94","author":"H Huikuri","year":"1996","unstructured":"Huikuri H, Pikkujamsa S, Airksien J, et al.: Sex-related differences in autonomic modulation of heart rate in middle-aged subjects. Circulation 1996, 94:122\u2013125.","journal-title":"Circulation"},{"key":"59_CR14","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1161\/01.HYP.30.6.1538","volume":"30","author":"K Sudhir","year":"1997","unstructured":"Sudhir K, Esler M, Jennings G, et al.: Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal women. Hypertension 1997, 30:1538\u20131543.","journal-title":"Hypertension"},{"key":"59_CR15","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/0002-9378(92)91783-7","volume":"167","author":"SR Lindheim","year":"1992","unstructured":"Lindheim SR, Legro RS, Bernstein L, et al.: Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. Am J Obstet Gynecol 1992, 167:1831\u20131836.","journal-title":"Am J Obstet Gynecol"},{"key":"59_CR16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00004872-199917040-00010","volume":"17","author":"BH Sung","year":"1999","unstructured":"Sung BH, Ching M, Izzo JL, et al.: Estrogen improves norepinephrine-induced vasoconstriction in postmenopausal women. J Hypertens 1999, 17:523\u2013528.","journal-title":"J Hypertens"},{"key":"59_CR17","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1161\/01.CIR.103.24.2903","volume":"103","author":"W Vongpatanasin","year":"2001","unstructured":"Vongpatanasin W, Tuncel M, Mansour Y, et al.: Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women. Circulation 2001, 103:2903\u20132908.","journal-title":"Circulation"},{"key":"59_CR18","first-page":"344","volume":"86","author":"G Weitz","year":"2001","unstructured":"Weitz G, Elam M, Born J, et al.: Postmenopausal estrogen administration suppresses muscle sympathetic nerve activity. J Clin Endocrinol Metab 2001, 86:344\u2013348.","journal-title":"J Clin Endocrinol Metab"},{"key":"59_CR19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/01.CIR.95.1.39","volume":"95","author":"H Schunkert","year":"1997","unstructured":"Schunkert H, Danser AHJ, Hense H-W, et al.: Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 1997, 95:39\u201345.","journal-title":"Circulation"},{"key":"59_CR20","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00004872-199715070-00003","volume":"15","author":"BK Bridget","year":"1997","unstructured":"Bridget BK, Weddle D, Anthony MS, et al.: Effect of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys. J Hypertens 1997, 15:719\u2013726.","journal-title":"J Hypertens"},{"key":"59_CR21","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1161\/01.CIR.97.22.2197","volume":"97","author":"G Nickenig","year":"1998","unstructured":"Nickenig G, Baumer A, Anselm T, et al.: Estrogen modulates AT1 receptor gene expression in vitro and vivo. Circulation 1998, 97:2197\u20132201.","journal-title":"Circulation"},{"key":"59_CR22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0008-6363(01)00527-2","volume":"53","author":"RK Dubey","year":"2002","unstructured":"Dubey RK, Oparil S, Imthurn B, et al.: Sex hormones and hypertension. Cardiovasc Res 2002, 53:688\u2013708. This is a comprehensive review of potential mechanisms by which sex hormones can affect blood pressure.","journal-title":"Cardiovasc Res"},{"key":"59_CR23","first-page":"R1934","volume":"281","author":"Z Fang","year":"2001","unstructured":"Fang Z, Carlson SH, Chen YF, et al.: Estrogen depletion induces NaCl-sensitive hypertension in female spontaneously hypertensive rats. Am J Physiol 2001, 281:R1934-R1939.","journal-title":"Am J Physiol"},{"key":"59_CR24","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1152\/jappl.2001.91.5.2005","volume":"91","author":"CK Roberts","year":"2001","unstructured":"Roberts CK, Vaziri ND, Barnard RJ: Protective effects of estrogen on gender-specific development of diet-induced hypertension. J Appl Physiol 2001, 91:2005\u20132009.","journal-title":"J Appl Physiol"},{"key":"59_CR25","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1161\/01.CIR.101.19.2258","volume":"101","author":"A Virdis","year":"2000","unstructured":"Virdis A, Ghiadoni L, Pinto S, et al.: Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women. Circulation 2000, 101:2258\u20132263.","journal-title":"Circulation"},{"key":"59_CR26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0006-2952(83)90660-3","volume":"32","author":"KT Shiverick","year":"1983","unstructured":"Shiverick KT, Notelovitz M: Mestranol-induced hypertension; characterization of cytochrome P-450 dependent catechol estrogen formation in brain microsomes. Biochem Pharmacol 1983, 32:101\u2013106.","journal-title":"Biochem Pharmacol"},{"key":"59_CR27","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/01.HYP.0000046924.94886.EF","volume":"41","author":"LA Fortepiani","year":"2003","unstructured":"Fortepiani LA, Zhang H, Racusen L, et al.: Characterization of an animal model of postmenopausal hypertension in spontaneously hypertensive rates. Hypertension 2003, 41:640\u2013645.","journal-title":"Hypertension"},{"key":"59_CR28","first-page":"2499","volume":"86","author":"NM Chan","year":"2001","unstructured":"Chan NM, MacAllister RJ, Colhoun HM, et al.: Changes in endothelium-dependent vasodilatation and \u03b1-adrenergic responses in resistance vessels during the menstrual cycle in healthy women. J Clin Endocrinol Metab 2001, 86:2499\u20132504.","journal-title":"J Clin Endocrinol Metab"},{"key":"59_CR29","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/01.HYP.37.5.1199","volume":"37","author":"JF Reckelhoff","year":"2001","unstructured":"Reckelhoff JF: Gender differences in the regulation of blood pressure. Hypertension 2001, 37:1199\u20131208.","journal-title":"Hypertension"},{"key":"59_CR30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2105\/AJPH.66.1.79","volume":"66","author":"JM Kotchen","year":"1976","unstructured":"Kotchen JM, Kotchen TA, Humphrey R, et al.: Hypertension detection and control in a rural white Kentucky community. Am J Public Health 1976, 66:79\u201381.","journal-title":"Am J Public Health"},{"key":"59_CR31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/bmj.1.6111.472","volume":"1","author":"RF Heller","year":"1978","unstructured":"Heller RF, Jacobs HS: Coronary heart disease in relation to age, sex, and the menopause. BMJ 1978, 1:472\u2013474.","journal-title":"BMJ"},{"key":"59_CR32","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/oxfordjournals.aje.a112228","volume":"103","author":"MC Hjortland","year":"1976","unstructured":"Hjortland MC, McNamara PM, Kannel WB: Some atherogenic concomitants of menopause: the Framingham Study. Am J Epidemiol 1976, 103:304\u2013311. This study carefully, uniformly, and prospectively documents the effect of menopause on blood pressure levels in a large populationbased sample.","journal-title":"Am J Epidemiol"},{"key":"59_CR33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJM198909073211004","volume":"321","author":"KA Mathews","year":"1989","unstructured":"Mathews KA, Meilahn E, Kuller LH, et al.: Menopause and risk factors for coronary heart disease. N Engl J Med 1989, 321:641\u2013646.","journal-title":"N Engl J Med"},{"key":"59_CR34","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.1967.03130120026007","volume":"201","author":"JH Laragh","year":"1967","unstructured":"Laragh JH, Sealy JE, Ledingham JGG, Newton MA: Oral contraceptives, renin, aldosterone and high blood pressure. JAMA 1967, 201:918\u2013922.","journal-title":"JAMA"},{"key":"59_CR35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7326\/0003-4819-74-1-13","volume":"74","author":"MG Crane","year":"1971","unstructured":"Crane MG, Harris JJ, Winsor W: Hypertension, oral contraceptive agents, and conjugated estrogens. Ann Intern Med 1971, 74:13\u201321.","journal-title":"Ann Intern Med"},{"key":"59_CR36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(71)91087-7","volume":"1","author":"RJ Weir","year":"1971","unstructured":"Weir RJ, Briggs E, Mack A, et al.: Blood pressure in women after one year of oral contraception. Lancet 1971, 1:467\u2013471.","journal-title":"Lancet"},{"key":"59_CR37","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/bmj.1.5907.533","volume":"1","author":"RJ Weir","year":"1974","unstructured":"Weir RJ, Briggs E, Mack A, et al.: Blood pressure in women taking oral contraceptives. BMJ 1974, 1:533\u2013535.","journal-title":"BMJ"},{"key":"59_CR38","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1001\/jama.1977.03270500051024","volume":"237","author":"IR Fisch","year":"1977","unstructured":"Fisch IR, Frank J: Oral contraceptives and blood pressure. JAMA 1977, 237:2499\u20132503. Both cross-sectional and longitudinal analyses of data from a large sample of women enrolled in a prepaid medical care plan provide evidence of a small rise in blood pressure with oral contraceptive use, which is reversible.","journal-title":"JAMA"},{"key":"59_CR39","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0021-9681(79)90095-X","volume":"32","author":"JM Kotchen","year":"1979","unstructured":"Kotchen JM, Kotchen TA, Cottrill CM, et al.: Blood pressures in young mothers and their first children 3-6 years following hypertension during pregnancy. J Chron Dis 1979, 32:653\u2013659.","journal-title":"J Chron Dis"},{"key":"59_CR40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/bmj.285.6339.403","volume":"285","author":"K-T Khaw","year":"1982","unstructured":"Khaw K-T, Peart WS: Blood pressure and contraceptive use. BMJ 1982, 285:403\u2013407.","journal-title":"BMJ"},{"key":"59_CR41","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0140-6736(77)90888-1","volume":"2","author":"TW Meade","year":"1977","unstructured":"Meade TW, Haines AP, North WRS, et al.: H\u00e6mostatic, lipid, and blood pressure profiles of women on oral contraceptives containing 50 mg or 30 mg estrogen. Lancet 1977, 2:948\u2013951.","journal-title":"Lancet"},{"key":"59_CR42","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/oxfordjournals.aje.a114598","volume":"125","author":"HB Hubert","year":"1987","unstructured":"Hubert HB, Eaker ED, Garrison RJ, Castelli WP: Life-style correlates of risk factor change in young adults: an eight-year study of coronary heart disease risk factors in the Framingham offspring. Am J Epidemiol 1987, 125:812\u2013831.","journal-title":"Am J Epidemiol"},{"key":"59_CR43","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1471-0528.1984.tb04747.x","volume":"91","author":"ESB Wilson","year":"1984","unstructured":"Wilson ESB, Cruickshank J, McMaster M, Weir RJ: A prospective controlled study of the effect of blood pressure of contraceptive preparations containing different types and dosage of progestogen. Br J Obstet Gyaecol 1984, 91:1254\u20131260.","journal-title":"Br J Obstet Gyaecol"},{"key":"59_CR44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/ije\/14.3.389","volume":"14","author":"V Cairns","year":"1985","unstructured":"Cairns V, Keil U, Doering A, et al.: Oral contraceptive use and blood pressure in a German metropolitan population. Internation J Epidemiol 1985, 14:389\u2013395. This prospective study of the effects of oral contraceptives on blood pressure is particularly informative because subjects are randomly selected from the general population.","journal-title":"Internation J Epidemiol"},{"key":"59_CR45","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJM199305273282108","volume":"328","author":"DR Baird","year":"1993","unstructured":"Baird DR, Glasier AF: Hormonal contraception. N Engl J Med 1993, 328:1543\u20131549.","journal-title":"N Engl J Med"},{"key":"59_CR46","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/0002-9378(72)90811-3","volume":"112","author":"WN Spellacy","year":"1972","unstructured":"Spellacy WN, Birk SA: The effect of intrauterine devices, oral contraceptives, estrogens, and progestogens on blood pressure. Am J Obstet Gynecol 1972, 112:912\u2013919.","journal-title":"Am J Obstet Gynecol"},{"key":"59_CR47","first-page":"3","volume-title":"Oral contraceptives and health\u2014some recent observations","author":"C Kay","year":"1978","unstructured":"Kay C: Oral contraceptives and health\u2014some recent observations. In International Symposium on Hormonal Contraception. Proceedings of a symposium held in Utrecht, The Netherlands, September 1977. Edited by Haspels AA, Kay CR. Amsterdam-Oxford: Excerpta Medica; 1978:3\u201310."},{"key":"59_CR48","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00004872-199603000-00010","volume":"14","author":"B Heintz","year":"1996","unstructured":"Heintz B, Schmauder C, Witte K, et al.: Blood pressure rhythm and endocrine functions in normotensive women on oral contraceptives. J Hypertension 1996, 14:333\u2013339. Day-night blood pressure differences are described among users and nonusers of oral contraceptives.","journal-title":"J Hypertension"},{"key":"59_CR49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.94.3.483","volume":"94","author":"L Chasan-Taber","year":"1996","unstructured":"Chasan-Taber L, Willet WC, Manson JE, et al.: Prospective study of oral contraceptives and hypertension among women in the United States. Circulation 1996, 94:483\u2013489.","journal-title":"Circulation"},{"key":"59_CR50","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/oxfordjournals.aje.a113023","volume":"112","author":"BA Blumenstein","year":"1980","unstructured":"Blumenstein BA, Douglas MB, Hall WD: Blood pressure changes and oral contraceptive use: a study of 2676 black women in the southeastern United States. Am J Epidemiol 1980, 112:539\u2013552.","journal-title":"Am J Epidemiol"},{"key":"59_CR51","doi-asserted-by":"crossref","first-page":"821","DOI":"10.7326\/0003-4819-120-10-199405150-00002","volume":"120","author":"Coditz GA for The Nurses\u2019 Health Study Research Group","year":"1994","unstructured":"Coditz GA for The Nurses\u2019 Health Study Research Group: Oral contraceptive use and mortality during 12 years of follow-up: The Nurses\u2019 Health Study. Ann Intern Med 1994, 120:821\u2013826.","journal-title":"Ann Intern Med"},{"key":"59_CR52","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7326\/0003-4819-130-7-199904060-00002","volume":"130","author":"NL Keating","year":"1999","unstructured":"Keating NL, Cleary PD, Rossi AS, et al.: Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med 1999, 130:545\u2013553.","journal-title":"Ann Intern Med"},{"key":"59_CR53","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1001\/jama.289.24.3241","volume":"289","author":"PC Austin","year":"2003","unstructured":"Austin PC, Mamdani MM, Tu K, Jaakkimainen L: Prescriptions for estrogen replacement therapy in Ontario before and after publication of the Women\u2019s Health Initiative Study [research letter]. JAMA 2003, 289:3241\u20133242.","journal-title":"JAMA"},{"key":"59_CR54","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"Writing Group for the Women\u2019s Health Initiative","year":"2002","unstructured":"Writing Group for the Women\u2019s Health Initiative: Risks and benefits of estrogen plus progestin in health postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial. JAMA 2002, 288:321\u2013333. The strength of this study lies in the randomized design, large study population, and careful follow-up of women.","journal-title":"JAMA"},{"key":"59_CR55","first-page":"29","volume":"82","author":"RA Lobo","year":"1987","unstructured":"Lobo RA: Cardiovascular effects of estrogen deprivation. Proceedings of a symposium on the long-term effects of estrogen deprivation. Post Grad Med (Suppl) 1987, 82:29\u201330.","journal-title":"Post Grad Med (Suppl)"},{"key":"59_CR56","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/hc2901.092200","volume":"104","author":"L Mosca","year":"2001","unstructured":"Mosca L, Collins P, Herrington DM, et al.: Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Assocation. Circulation 2001, 104:499\u2013503.","journal-title":"Circulation"},{"key":"59_CR57","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/bmj.319.7214.890","volume":"319","author":"K Rodstrom","year":"1999","unstructured":"Rodstrom K, Bengtsson C, Lissner L, Bjorkelund C: Pre-existing risk factor profiles in users and non-users of hormone replacement therapy: prospective cohort study in Gothenburg, Sweden. BMJ 1999, 319:890\u2013893.","journal-title":"BMJ"},{"key":"59_CR58","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.ATV.19.4.893","volume":"19","author":"M Cushman","year":"1999","unstructured":"Cushman M, Meilahn EN, Psaty BM, et al.: Hormone replacement therapy, inflammation, and hemostasis in elderly women. Arterioscler Thromb Vasc Biol 1999, 19:893\u2013899.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"59_CR59","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/01.CIR.88.5.2163","volume":"88","author":"TA Manolio","year":"1993","unstructured":"Manolio TA, Furberg CD, Shemanski L, et al.: Progression of coronary artery disease: associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation 1993, 88:2163\u20132171.","journal-title":"Circulation"},{"key":"59_CR60","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.CIR.75.6.1102","volume":"75","author":"TL Bush","year":"1987","unstructured":"Bush TL, Barrett-Conner E, Cowan LD, et al.: Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987, 75:1102\u20131109.","journal-title":"Circulation"},{"key":"59_CR61","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM198510243131702","volume":"313","author":"PWF Wilson","year":"1985","unstructured":"Wilson PWF, Garrison RJ, Castelli WP: Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med 1985, 313:1038\u20131043.","journal-title":"N Engl J Med"},{"key":"59_CR62","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/0003-4819-135-4-200108210-00007","volume":"135","author":"A Scuteri","year":"2001","unstructured":"Scuteri A, Bos AJG, Brant LJ, et al.: Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women. Ann Intern Med 2001, 135:229\u2013238.","journal-title":"Ann Intern Med"},{"key":"59_CR63","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1001\/jama.1979.03290460031015","volume":"241","author":"E Barrett-Connor","year":"1979","unstructured":"Barrett-Connor E, Brown WV, Turner J, et al.: Heart disease risk factors and hormone use in postmenopausal women. JAMA 1979, 241:2167\u20132169.","journal-title":"JAMA"},{"key":"59_CR64","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1001\/jama.1989.03420140097034","volume":"261","author":"E Barrett-Connor","year":"1989","unstructured":"Barrett-Connor E, Wingard DL, Criqui MH: Postmenopausal estrogen use and heart disease risk factors in the 1980s. Rancho Bernardo, California, revisited. JAMA 1989, 261:2095\u20132100.","journal-title":"JAMA"},{"key":"59_CR65","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM199109123251102","volume":"325","author":"MJ Stampfer","year":"1991","unstructured":"Stampfer MJ, Colditz GA, Willett WC, et al.: Postmenopausal estrogen therapy and cardiovascular disease: ten year followup from the Nurses\u2019 Health Study. N Engl J Med 1991, 325:756\u2013762.","journal-title":"N Engl J Med"},{"key":"59_CR66","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","volume":"273","author":"The Writing Group for the PEPI Trial","year":"1995","unstructured":"The Writing Group for the PEPI Trial: Effects of estrogen and estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen\/ Progestin Interventions (PEPI) Trial. JAMA 1995, 273:199\u2013208. The randomized design of this study provides unbiased estimates of the effects of combined hormone therapy on blood pressures.","journal-title":"JAMA"},{"key":"59_CR67","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/01.ATV.21.2.262","volume":"21","author":"P Angerer","year":"2001","unstructured":"Angerer P, St\u00f6rk S, Kothny W, et al.: Effect of oral postmenopausal hormone replacement on progression of atherosclerosis: a randomized, controlled trial. Arterioscler Thromb Vasc Biol 2001, 21:262\u2013268.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"59_CR68","doi-asserted-by":"crossref","first-page":"31G","DOI":"10.1016\/0002-9149(89)90953-3","volume":"64","author":"HR Superko","year":"1989","unstructured":"Superko HR: Drug therapy and the prevention of atherosclerosis in humans. Am J Cardiol 1989, 64:31G-38G.","journal-title":"Am J Cardiol"},{"key":"59_CR69","first-page":"165","volume":"7","author":"DP Byar","year":"1988","unstructured":"Byar DP, Corle DK: Hormone therapy for prostate cancer: results of the Veteran Administration Cooperative Urological Research Group Studies. NCI Monographs 1988, 7:165\u2013170.","journal-title":"NCI Monographs"},{"key":"59_CR70","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0022-5347(17)45620-5","volume":"135","author":"HJ Voogt de","year":"1986","unstructured":"de Voogt HJ, Smith PH, Pavone-Macaluso M, et al.: Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate, and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762. J Urol 1986, 135:303\u2013307.","journal-title":"J Urol"},{"key":"59_CR71","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1136\/bmj.291.6507.1461","volume":"291","author":"B Blyth","year":"1985","unstructured":"Blyth B, McRae CU, Espiner EA, et al.: Effect of stilboestrol on sodium balance, cardiac state, and renin-angiotensinaldosterone activity in prostatic carcinoma. BMJ 1985, 291:1461\u20131464.","journal-title":"BMJ"},{"key":"59_CR72","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/hy1101.095006","volume":"38","author":"PA Komesaroff","year":"2001","unstructured":"Komesaroff PA, Fullerton M, Esler MD, et al.: Low-dose estrogen supplementation improves vascular function in hypogonadal men. Hypertension 2001, 38:1011\u20131016.","journal-title":"Hypertension"},{"key":"59_CR73","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1365-2265.2002.01542.x","volume":"56","author":"PA Komesaroff","year":"2002","unstructured":"Komesaroff PA, Fullerton M, Esler MD, et al.: Oestrogen supplementation attenuates responses to psychological stress in elderly men rendered hypogonadal after treatment for prostate cancer. Clin Endocrinol 2002, 56:745\u2013753.","journal-title":"Clin Endocrinol"},{"key":"59_CR74","first-page":"836","volume":"79","author":"G Rio Del","year":"1994","unstructured":"Del Rio G, Velardo A, Zizzo G, et al.: Effect of estradiol on the sympathoadrenal response to mental stress in normal men. J Clin Endocrinol Metab 1994, 79:836\u2013840.","journal-title":"J Clin Endocrinol Metab"},{"key":"59_CR75","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1471-0528.1986.tb07949.x","volume":"93","author":"AJ Slater","year":"1986","unstructured":"Slater AJ, Gude N, Clarke IJ, Walters WA: Haemodynamic changes and left ventricular performance during high-dose oestrogen administration to male transsexuals. Br J Obstet Gynaecol 1986, 93:532\u2013538.","journal-title":"Br J Obstet Gynaecol"},{"key":"59_CR76","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00019501-200005000-00008","volume":"11","author":"G New","year":"2000","unstructured":"New G, Berry KL, Cameron JD, et al.: Long-term oestrogen treatment does not alter systemic arterial compliance and haemodynamics in biological males. Coron Artery Dis 2000, 11:253\u2013259.","journal-title":"Coron Artery Dis"},{"key":"59_CR77","unstructured":"US Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research (CDER): Combined oral contraceptives: labeling for healthcare providers and patients. Rockville, MD: June 2000."},{"key":"59_CR78","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research (CDER): Estrogen and estrogen\/progestin drum products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms: recommendations for clinical evaluation. Rockville, MD: January 2003."}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-003-0059-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-003-0059-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-003-0059-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:16:06Z","timestamp":1559420166000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-003-0059-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["59"],"URL":"https:\/\/doi.org\/10.1007\/s11906-003-0059-0","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}